27 results
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
practice. He has served in a variety of leadership roles over 20 years at L.E.K., including Global Head, Healthcare Practice, Global Leadership Team … by Ultragenyx in November 2017. Prior leadership roles have included the head of global research and development at Merck Serono and SVP, Global Development
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
could hinder their ability to hire, retain or deploy key leadership and other personnel, prevent new or modified products from being developed, review … Director and Vice Chairman of L.E.K. Consulting’s Global Healthcare practice. He has served in a variety of leadership roles over 20 years at L.E.K
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
with no scientific, operational or public company leadership experience. Rather than persuade with its analysis, Rubric appears to acknowledge that it can only … by Merck & Co. in 2020. Prior to ArQule Inc., Dr. Schwartz was Chief Medical Officer at Ziopharm, having previously held several senior leadership
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
obligations that occurred during her tenure on the board. Mr. Roberts and Mr. Rosen have no biotechnology company leadership nor operating experience
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
22 Aug 22
Notifies Rubric of Certain Deficiencies in its Notice Purporting to Call a General Meeting of Shareholders
4:06pm
. Prior leadership roles have included the head of global research and development at Merck Serono and SVP, Global Development at Bristol Myers-Squibb
6-K
EX-99.1
v8xn2k x896fxtuv2uf4
17 May 22
Mereo BioPharma Announces Appointment of Dr. Abdul Mullick to Board of Directors
8:19am
6-K
EX-99.1
ko0r4ox
20 Sep 21
Mereo BioPharma Announces Appointment of Pierre Jacquet, M.D., Ph.D. to Board of Directors
8:20am
6-K
EX-99.1
89v3hb
28 Sep 20
Mereo BioPharma Announces Changes to Board of Directors
8:08am
6-K
EX-99.3
cz3c3glsk58w 7bdb
30 Jun 20
Result of Annual General Meeting
4:07pm
6-K
k3z92wci453fg29p1kzu
16 Jun 20
Current report (foreign)
4:13pm
6-K
g89gr4j usiaa4hc
16 Jul 19
Current report (foreign)
8:21am
20-F
EX-4.19
j7m9i5i
29 Apr 19
Annual report (foreign)
4:59pm
F-4
EX-10.8
a5dve5h xzlxl
25 Jan 19
Registration of securities (foreign)
12:00am